Additionally, protecting the encapsulated biomaterial capsules can provide a controlled release of therapeutic agents, such as insulin or growth factors, which are essential for treating chronic conditions like diabetes and cancer [19,20]. The gene discussed is INS; the disease is diabetes mellitus.